Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures

IMPORTANCE: Currently, rates of referral of patients with peritoneal metastasis in the United States who qualify for cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) are low, in part because of the misperception of high morbidity and mortality rates. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Foster, Jason M., Sleightholm, Richard, Patel, Asish, Shostrom, Valerie, Hall, Bradley, Neilsen, Beth, Bartlett, David, Smith, Lynette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484874/
https://www.ncbi.nlm.nih.gov/pubmed/30646202
http://dx.doi.org/10.1001/jamanetworkopen.2018.6847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484874/
https://www.ncbi.nlm.nih.gov/pubmed/30646202
http://dx.doi.org/10.1001/jamanetworkopen.2018.6847

Ejemplares similares